| Randall L Savell, MD | |
|
3520 Airport Blvd Nw Ste F, Wilson, NC 27896 | |
| (252) 206-5622 | |
| (252) 206-5623 |
| Full Name | Randall L Savell |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 33 Years |
| Location | 3520 Airport Blvd Nw Ste F, Wilson, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497849087 | NPI | - | NPPES |
| 8974623 | Medicaid | NC | |
| 74623 | Other | NC | BCBS NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 34154 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cherokee Indian Hospital Authority | Cherokee, NC | Hospital |
| Harris Regional Hospital | Sylva, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Western Carolina Digestive Consultants Pa | 8820065477 | 9 |
| Dlp Western Carolina Physician Practices Llc | 9032338975 | 112 |
News Archive
A recent study conducted at Marshall University may eventually help scientists develop new treatments for prostate cancer, the most common malignancy in American men.
The U.S. Food and Drug Administration has approved for marketing the first LASIK device designed for treating one eye to see far away objects and the other eye for close-up vision.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced that it has completed recruitment of patients in the Phase 2b study of TC-5619 as a treatment for negative symptoms and cognitive dysfunction in schizophrenia.
Scientists may be able to minimize the failure rate of drugs for diseases linked to high-calorie diets, such as colon cancer and type 2 diabetes, if they test treatments using a pig model, according to an international team of researchers.
› Verified 6 days ago
| Entity Name | Western Carolina Digestive Consultants Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790870830 PECOS PAC ID: 8820065477 Enrollment ID: O20040913001268 |
News Archive
A recent study conducted at Marshall University may eventually help scientists develop new treatments for prostate cancer, the most common malignancy in American men.
The U.S. Food and Drug Administration has approved for marketing the first LASIK device designed for treating one eye to see far away objects and the other eye for close-up vision.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced that it has completed recruitment of patients in the Phase 2b study of TC-5619 as a treatment for negative symptoms and cognitive dysfunction in schizophrenia.
Scientists may be able to minimize the failure rate of drugs for diseases linked to high-calorie diets, such as colon cancer and type 2 diabetes, if they test treatments using a pig model, according to an international team of researchers.
› Verified 6 days ago
| Entity Name | Carolina Gastroenterology Specialists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962523050 PECOS PAC ID: 0749386969 Enrollment ID: O20070504000403 |
News Archive
A recent study conducted at Marshall University may eventually help scientists develop new treatments for prostate cancer, the most common malignancy in American men.
The U.S. Food and Drug Administration has approved for marketing the first LASIK device designed for treating one eye to see far away objects and the other eye for close-up vision.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced that it has completed recruitment of patients in the Phase 2b study of TC-5619 as a treatment for negative symptoms and cognitive dysfunction in schizophrenia.
Scientists may be able to minimize the failure rate of drugs for diseases linked to high-calorie diets, such as colon cancer and type 2 diabetes, if they test treatments using a pig model, according to an international team of researchers.
› Verified 6 days ago
| Entity Name | Carolina Gastroenterology Specialists Pllc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1063667020 PECOS PAC ID: 0749386969 Enrollment ID: O20080718000133 |
News Archive
A recent study conducted at Marshall University may eventually help scientists develop new treatments for prostate cancer, the most common malignancy in American men.
The U.S. Food and Drug Administration has approved for marketing the first LASIK device designed for treating one eye to see far away objects and the other eye for close-up vision.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced that it has completed recruitment of patients in the Phase 2b study of TC-5619 as a treatment for negative symptoms and cognitive dysfunction in schizophrenia.
Scientists may be able to minimize the failure rate of drugs for diseases linked to high-calorie diets, such as colon cancer and type 2 diabetes, if they test treatments using a pig model, according to an international team of researchers.
› Verified 6 days ago
| Entity Name | Dlp Western Carolina Physician Practices Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609281641 PECOS PAC ID: 9032338975 Enrollment ID: O20140908002531 |
News Archive
A recent study conducted at Marshall University may eventually help scientists develop new treatments for prostate cancer, the most common malignancy in American men.
The U.S. Food and Drug Administration has approved for marketing the first LASIK device designed for treating one eye to see far away objects and the other eye for close-up vision.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced that it has completed recruitment of patients in the Phase 2b study of TC-5619 as a treatment for negative symptoms and cognitive dysfunction in schizophrenia.
Scientists may be able to minimize the failure rate of drugs for diseases linked to high-calorie diets, such as colon cancer and type 2 diabetes, if they test treatments using a pig model, according to an international team of researchers.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Randall L Savell, MD 3520 Airport Blvd Nw Ste F, Wilson, NC 27896-8674 Ph: (252) 206-5622 | Randall L Savell, MD 3520 Airport Blvd Nw Ste F, Wilson, NC 27896 Ph: (252) 206-5622 |
News Archive
A recent study conducted at Marshall University may eventually help scientists develop new treatments for prostate cancer, the most common malignancy in American men.
The U.S. Food and Drug Administration has approved for marketing the first LASIK device designed for treating one eye to see far away objects and the other eye for close-up vision.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced that it has completed recruitment of patients in the Phase 2b study of TC-5619 as a treatment for negative symptoms and cognitive dysfunction in schizophrenia.
Scientists may be able to minimize the failure rate of drugs for diseases linked to high-calorie diets, such as colon cancer and type 2 diabetes, if they test treatments using a pig model, according to an international team of researchers.
› Verified 6 days ago
Bonnie Ann Boshart, FNP Gastroenterology Medicare: Medicare Enrolled Practice Location: 200 Glendale Dr W, Wilson, NC 27893 Phone: 252-399-0737 Fax: 252-399-0747 | |
Dr. Jessica Heather Mckee, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2635 Tilghman Rd N, Wilson, NC 27896 Phone: 252-991-2067 Fax: 252-991-2068 | |
Richard L Burdick, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 200 Glendale Drive, Wilson, NC 27893 Phone: 252-399-0737 Fax: 252-399-0747 | |
Ameet Kumar, M.D Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1705 Tarboro St Sw, Wilson, NC 27893 Phone: 252-399-8040 | |
Dr. Sopna E Jacob, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 1700 Tarboro St W, Suite 200, Wilson, NC 27893 Phone: 252-399-5310 Fax: 252-399-5311 | |
Dr. Anwar Darwish Al-haidary, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2503 Wooten Blvd Sw, Wilson, NC 27893 Phone: 252-243-2268 Fax: 252-243-2917 | |
Dr. Sanjay Cherukuri, SANJAY CHERUKURI Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2605 Forest Hills Rd Sw, Wilson, NC 27893 Phone: 252-243-7161 Fax: 252-243-7242 |